Transcatheter arterialization of deep veins resulted in 6-month amputation-free survival in 66.1% of 105 patients with chronic limb-threatening ischemia and no conventional options for treatment.
Mehdi H. Shishehbor, Richard J. Powell, Miguel F. Montero-Baker, Anahita Dua, Jorge L. Martínez-Trabal, Matthew C. Bunte, Arthur C. Lee, Andrew S. Mugglin, Joseph L. Mills, Alik Farber, Daniel G. Clair, the PROMISE II Investigators
In a phase 4, double-blind, randomized trial, vedolizumab therapy was more effective than placebo in inducing remission in patients with chronic pouchitis after ileal pouch–anal anastomosis for ulcerative colitis.
Simon Travis, Mark S. Silverberg, Silvio Danese, Paolo Gionchetti, Mark Löwenberg, Vipul Jairath, Brian G. Feagan, Brian Bressler, Marc Ferrante, Ailsa Hart, Dirk Lindner, Armella Escher, Stephen Jones, Bo Shen, the EARNEST Study Group
Peripheral artery disease affects more than 200 million persons worldwide and is associated with substantial morbidity and mortality.1 More than 1 million persons in the United States have chronic limb-threatening ischemia, the most severe manifestation of peripheral artery disease, with a substantial risk of amputation and death 1...
Douglas E. Drachman
RMEI LIGHTNING TALKS
4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far
RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
Allergy & Immunology
Effectiveness of 5-year IBD Provider Online Educational Intervention Program
There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.